87 related articles for article (PubMed ID: 29400661)
1. The Mediator complex subunit MED15, a promoter of tumour progression and metastatic spread in renal cell carcinoma.
Weiten R; Müller T; Schmidt D; Steiner S; Kristiansen G; Müller SC; Ellinger J; Syring I
Cancer Biomark; 2018; 21(4):839-847. PubMed ID: 29400661
[TBL] [Abstract][Full Text] [Related]
2. The knockdown of the mediator complex subunit MED30 suppresses the proliferation and migration of renal cell carcinoma cells.
Syring I; Weiten R; Müller T; Schmidt D; Steiner S; Müller SC; Kristiansen G; Ellinger J
Ann Diagn Pathol; 2018 Jun; 34():18-26. PubMed ID: 29661722
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of Mediator complex subunit MED15 in testicular germ cell tumors.
Klümper N; Syring I; Offermann A; Adler D; Vogel W; Müller SC; Ellinger J; Strauß A; Radzun HJ; Ströbel P; Brägelmann J; Perner S; Bremmer F
Diagn Pathol; 2015 Sep; 10():165. PubMed ID: 26377566
[TBL] [Abstract][Full Text] [Related]
4. The knockdown of the Mediator complex subunit MED15 restrains urothelial bladder cancer cells' malignancy.
Syring I; Weiten R; Müller T; Schmidt D; Steiner S; Kristiansen G; Müller SC; Ellinger J
Oncol Lett; 2018 Sep; 16(3):3013-3021. PubMed ID: 30127891
[TBL] [Abstract][Full Text] [Related]
5. The Contrasting Role of the Mediator Subunit MED30 in the Progression of Bladder Cancer.
Syring I; Weiten R; Müller T; Schmidt D; Steiner S; Kristiansen G; Müller SC; Ellinger J
Anticancer Res; 2017 Dec; 37(12):6685-6695. PubMed ID: 29187445
[TBL] [Abstract][Full Text] [Related]
6. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N
BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
[TBL] [Abstract][Full Text] [Related]
7. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
8. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
[TBL] [Abstract][Full Text] [Related]
9. EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells.
Cho MC; Cho SY; Yoon CY; Lee SB; Kwak C; Kim HH; Jeong H
PLoS One; 2015; 10(7):e0130975. PubMed ID: 26177500
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Abolhasani M; Shariftabrizi A; Rasti A; Asgari M
Cancer Biomark; 2018; 21(4):821-837. PubMed ID: 29286924
[TBL] [Abstract][Full Text] [Related]
11. Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma.
Liu L; Xu Z; Zhong L; Wang H; Jiang S; Long Q; Xu J; Guo J
BJU Int; 2016 Feb; 117(2):351-62. PubMed ID: 24612432
[TBL] [Abstract][Full Text] [Related]
12. Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels.
Horstmann M; Merseburger AS; von der Heyde E; Serth J; Wegener G; Mengel M; Feil G; Hennenlotter J; Nagele U; Anastasiadis A; Bokemeyer C; Stenzl A; Kuczyk M
J Cancer Res Clin Oncol; 2005 Nov; 131(11):715-22. PubMed ID: 16080018
[TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
[TBL] [Abstract][Full Text] [Related]
14. Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma.
Wakita T; Hayashi T; Nishioka J; Tamaru H; Akita N; Asanuma K; Kamada H; Gabazza EC; Ido M; Kawamura J; Suzuki K
Int J Cancer; 2004 Feb; 108(4):516-23. PubMed ID: 14696115
[TBL] [Abstract][Full Text] [Related]
15. miR-10b is a prognostic marker in clear cell renal cell carcinoma.
Khella HWZ; Daniel N; Youssef L; Scorilas A; Nofech-Mozes R; Mirham L; Krylov SN; Liandeau E; Krizova A; Finelli A; Cheng Y; Yousef GM
J Clin Pathol; 2017 Oct; 70(10):854-859. PubMed ID: 28360191
[TBL] [Abstract][Full Text] [Related]
16. TNF-α augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma.
Sun KH; Sun GH; Wu YC; Ko BJ; Hsu HT; Wu ST
J Cell Mol Med; 2016 Nov; 20(11):2020-2028. PubMed ID: 27297979
[TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular implications of MED15 in head and neck squamous cell carcinoma.
Adler D; Offermann A; Halbach R; Vogel W; Braun M; Kristiansen G; Bootz F; Wenzel J; Mikut R; Lengerke C; Reischl M; Schröck A; Perner S
Am J Pathol; 2015 Apr; 185(4):1114-22. PubMed ID: 25791637
[TBL] [Abstract][Full Text] [Related]
18. CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival.
Chong TW; Goh FY; Sim MY; Huang HH; Thike AA; Lim WK; Teh BT; Tan PH
J Clin Pathol; 2015 Mar; 68(3):200-5. PubMed ID: 25477528
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
[TBL] [Abstract][Full Text] [Related]
20. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
